Procyon Advisors, LLC Abbott Laboratories Transaction History

Procyon Advisors, LLC

$1.44 Billion
Q3 2024

A detailed history of Procyon Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Procyon Advisors, LLC holds 34,380 shares of ABT stock, worth $4.05 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

34,380

Previous 35,823 4.03%

Holding current value

$4.05 Million

Previous $3.72 Million 5.29%

% of portfolio

0.27%

Previous 0.28%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$100.07 - $118.13 $144,401 - $170,461	-1,443 Reduced 4.03%	34,380 $3.92 Million
Q2 2024 Aug 02, 2024	SELL	$100.73 - $112.44 $12,490 - $13,942	-124 Reduced 0.34%	35,823 $3.72 Million
Q1 2024 Apr 15, 2024	BUY	$109.52 - $120.96 $1.03 Million - $1.14 Million	9,425 Added 35.54%	35,947 $4.09 Million
Q4 2023 Jan 18, 2024	BUY	$90.19 - $110.4 $88,025 - $107,750	976 Added 3.82%	26,522 $2.92 Million
Q3 2023 Oct 10, 2023	BUY	$95.53 - $114.62 $555,315 - $666,286	5,813 Added 29.46%	25,546 $2.47 Million
Q2 2023 Jul 17, 2023	BUY	$100.78 - $112.29 $453,207 - $504,968	4,497 Added 29.52%	19,733 $2.15 Million
Q1 2023 Apr 10, 2023	BUY	$96.86 - $114.01 $683,734 - $804,796	7,059 Added 86.33%	15,236 $1.54 Million
Q4 2022 Jan 19, 2023	BUY	$95.06 - $111.52 $412,845 - $484,331	4,343 Added 113.28%	8,177 $0
Q3 2022 Oct 17, 2022	BUY	$96.76 - $112.03 $2,806 - $3,248	29 Added 0.76%	3,834 $371,000
Q2 2022 Jul 11, 2022	SELL	$102.07 - $123.37 $39,909 - $48,237	-391 Reduced 9.32%	3,805 $413,000
Q1 2022 Apr 18, 2022	BUY	$114.02 - $139.04 $14,936 - $18,214	131 Added 3.22%	4,196 $497,000
Q4 2021 Jan 18, 2022	SELL	$115.53 - $141.46 $9,473 - $11,599	-82 Reduced 1.98%	4,065 $572,000
Q3 2021 Oct 14, 2021	BUY	$116.66 - $129.06 $37,914 - $41,944	325 Added 8.5%	4,147 $490,000
Q2 2021 Jul 22, 2021	BUY	$105.79 - $124.53 $69,715 - $82,065	659 Added 20.83%	3,822 $443,000
Q1 2021 Apr 29, 2021	SELL	$108.84 - $128.23 $25,250 - $29,749	-232 Reduced 6.83%	3,163 $379,000
Q4 2020 Jan 19, 2021	SELL	$105.0 - $114.42 $20,790 - $22,655	-198 Reduced 5.51%	3,395 $372,000
Q3 2020 Oct 22, 2020	BUY	$91.64 - $111.29 $5,406 - $6,566	59 Added 1.67%	3,593 $391,000
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $11,102 - $14,210	145 Added 4.28%	3,534 $323,000
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $13,255 - $19,382	211 Added 6.64%	3,389 $267,000
Q4 2019 Feb 21, 2020	BUY	$78.51 - $87.4 $249,504 - $277,757	3,178 New	3,178 $276,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Procyon Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Procyon Advisors, LLC with notifications on news.

Account

Procyon Advisors, LLC Abbott Laboratories Transaction History